Abstract: This work reports on fully integrated "sample-insignal-out" microfluidic paper-based analytical devices (mPADs) relying on bioluminescence resonance energy transfer (BRET) switches for analyte recognition and colorimetric signal generation. The devices use BRET-based antibody sensing proteins integrated into vertically assembled layers of functionalizedpaper,and their design enables sample volumeindependent and fully reagent-free operation, including ondevice blood plasma separation. User operation is limited to the application of asingle drop (20-30 mL) of sample (serum, whole blood) and the acquisition of aphotograph 20 min after sample introduction, with no requirement for precise pipetting, liquid handling,o ra nalytical equipment except for ac amera. Simultaneous detection of three different antibodies (anti-HIV1, anti-HA, and anti-DEN1) in whole blood was achieved. Given its simplicity,this type of device is ideally suited for userfriendly point-of-care testing in low-resource environments.
Microfluidic paper-based analytical devices (mPA Ds), first introduced by Whitesides et al., [1] represent ac lass of microfluidic devices characterized by low material costs,c apillary force-driven sample transport, and being light-weight, disposable,a nd deliverable to end-users.R esearch has come as ignificant way in converting labor-intensive clinical assays into more user-friendly formats on paper platforms. [2] Nevertheless,s everal hurdles hampering widespread point-of-care (POC) application of mPA Ds remain.
[3] Quantitative colorimetric assays for example,r equire elimination of the influence of environmental light conditions, [4] whereas fluorescence-based detection potentially suffers from paper autofluorescence [5] or light scattering [6] and requires the use of an excitation light source.L iquid-handling steps pose another challenge to assay simplification. ELISA and Luminex methods require multiple liquid handling steps (such as pipetting, incubation, washing, and signal generation) [7] posing significant challenges in translating those assays from dedicated laboratory instruments into simple paper-based systems.W hile lateral flow immunochromatographic assays do not suffer from these drawbacks,t hey have limited sensitivity and generally show poor quantitative performance. [8] This applies,for example,toassays for the detection of antibodies in disease diagnostics [9] and in drug monitoringguided dose optimization of therapeutic antibodies. [10] Recently,w es uccessfully addressed some of the drawbacks of classical heterogeneous immunoassays by introducing an ovel type of bioluminescence resonance energy transfer (BRET)-based immunoassay integrating antibody binding and signal generation in as ingle protein switch referred to as LUMABS (Figure 1a) , making any washing Figure 1 . a) Schematic of the LUMABSworking principle with the "closed form" green light-emitting and the "open form" blue lightemitting protein sensor in the absence and presence of target antibody,respectively (NLuc = NanoLucl uciferase;m NG = mNeonGreen fluorescentprotein).
[11a] b) Schematic of amulti-layer 3D-mPAD. All layers are kept together through lamination. c) Schematic of the use of a3 D-mPAD for simultaneous detection of three different antibodies. steps unnecessary. [11] Antibody binding in LUMABS results in ac hange in emitted bioluminescence from green to blue. This ratiometric response offers significant advantages over intensity-based approaches,w hich are inherently influenced by factors not related to target analyte concentration. These properties and the absence of background fluorescence and scattered excitation light allowed direct detection of antibodies in blood plasma with LUMABS using amobile phone camera as detector.
[11a] BRET-based switches are not limited to antibody detection but have also been demonstrated for therapeutic drug monitoring of low-molecular weight compounds [12] and nucleic acids. [13] BRET-based ratiometric sensing is particularly useful for colorimetric assays on paper platforms because it eliminates challenges for mPA Ds associated with external light sources, environmental light conditions,and intensity-based signaling. An additional benefit of paper-based BRET signaling compared to solution phase assays is the suppressed absorption of the bioluminescent signal by blood components because of the short optical path length of thin paper layers. [12] While the latter advantage has already been demonstrated by performing the final read-out on filter paper, [12] current assay procedures still require complex and quantitative liquid handling steps such as cell separation, sample dilution, and substrate addition and mixing. These represent significant hurdles for practical application of BRET-based diagnostics in user-friendly point-of-care testing (POCT) by untrained users.
Herein, we have developed af ully integrated mPA Df or use with bioluminescent BRET sensors,d emonstrated for LUMABS-based detection of (multiple) antibodies in spiked whole blood. Figure 1b shows the design of our device consisting of multiple paper layers vertically arranged in al aminated 3D-mPA D. Thef irst layer (plasma separation membrane) serves as the sample pad, in which cellular components are separated from aw hole-blood sample.T he second layer contains the substrate (furimazine), which is dissolved into the vertically flowing sample liquid and carried along to the third layer containing the BRET-switching protein (LUMABS). Thea rrangement of paper layers for furimazine (non-patterned upper paper layer) and LUMABS immobilization (patterned lower paper layer) was chosen for simple device fabrication. It eliminates the requirement for precise alignment of multiple patterned papers,which would be necessary to achieve multi-target assays on asingle device in the case of reversed layer order (patterned LUMABS layer on top of patterned furimazine layer). After the formation of the antibody-LUMABS complex, the device is flipped and the bioluminescent signal collected by ad igital camera ( Figure 1c ). Details on single device layers and on device fabrication are provided in Figure S1 of the Supporting Information, together with information regarding the selection of the paper substrate.T he method and experimental setup applied for signal acquisition by ad igital camera are illustrated in Figure S2 . This 3D-mPA Dd esign has several important features:1 )Short flow paths compared to lateral flow designs allowing for rapid assays with low sample volumes,i ncluding viscous blood serum or plasma, 2) ondevice blood cell removal from whole blood, 3) separate storage of luciferase-integratingB RET sensors and corresponding substrates (luciferin) in close proximity,and 4) patterned signaling layer for simultaneous detection of multiple targets.Another challenge associated with mPA Ds is the fact that quantitative results depend on the applied sample volume because signal intensity relies on the absolute amount of analyte in the detection area rather than the concentration. We recently demonstrated that the closed space created by full lamination of a mPA Dc ontributes to limiting the sample volume absorbed by the paper substrate, allowing for sample volume-independent measurements. [14] The3 D-mPA Ds were therefore designed as closed compartments by complete device lamination for sample volumeindependent signaling.
Before integrated device assembly,w ef irst used simple spot tests with an HIV1-p17 antibody targeting LUMABS on wax-patterned paper to confirm that the antibody concentration-dependent response of LUMABS on paper is comparable to the one in bulk solution ( Figure S3 ). Having this confirmed, we next tested the performance in an integrated device.F irst, devices with the three signal detection areas modified with identical amounts of asingle type of LUMABS (anti-HIV-LUMABS,a nti-DEN-LUMABS,o ra nti-HA-LUMABS;F igure S1 d-1) were evaluated, allowing the collection of triplicate data points from as ingle sample application (20 mL; Figure 2a ). Them ean of the relative standard deviations for the hue values collected from the three detection areas of asingle device was below 1% for all assays,indicating alow variation in sample distribution to the three detection areas (Table S1 ). Moreover,s atisfactory batch-to-batch fabrication reproducibility was achieved for the manually assembled 3D-mPA Ds,s howing ar elative standard deviation of the mean of the c 50 values (indicating the antibody concentration resulting in 50% of the maximal hue change) below 1% (c 50 = 6.40 AE 0.06 nm)for three batches of anti-HIV1 detecting devices fabricated on three different days ( Figure S4) . Next, the colorimetric response of devices having three signal detection areas modified with different amounts of anti-HIV-LUMABS (100, 500, and 1000 fmol; Figure S1 d-2) was evaluated by titration with 0.1-100 nm of anti-HIV1p17 antibody.T he effective response range was found to depend on the amount of sensor protein, with high amounts of LUMABS requiring ah igher concentration of antibody to go from the green "closed state" of the sensor to the blue light-emitting antibody-bound "open" state.T his property could be exploited for measurements over an extended concentration range that cannot be achieved using asingle signal detection area. Thephotographs in Figure 2a ,b show the observed bioluminescence emission providing the basis for the measurement of hue values.
Thet hree detection areas can also be used for multiplex detection of three different antibodies.F igure 2c shows an experiment with the signal detection areas modified with three previously developed LUMABS targeting antiHIV1p17, anti-HA, and anti-Dengue antibodies (Figure S1 d-3) . While the extent of the sensor response to their target antibody varies for the different LUMABS,t he selectivity is excellent, showing no cross-talk between different detection areas (Figure 2c ).
An important advantage of the ratiometric,h ue-based readout approach used in this study is that the signal is independent of the bioluminescence intensity.T his is particularly important for bioluminescent sensors,a sb ioluminescence intensity typically decreases in time as ar esult of substrate turn-over and/or product inhibition. Ther esults shown in the photographs of Figure 2b for 0nm anti-HIV1 illustrate this point. Whereas the signal intensity varies substantially between the three detection areas because of the different amounts of sensor protein, the color as represented by the hue value is independent of signal intensity (Table S1 ). Figure S5 shows that hue values are stable and can be reliably detected as long as sufficient light is emitted, since the glow-type bioluminescence of the NanoLuc/furimazine system extends beyond 30 min.
Volume-independent analysis and long-term stability represent two important aspects of device performance for point-of-care applications.T he results shown in Figure 3 demonstrate that our 3D-mPA Ds allow sample volumeindependent analyses,p rovided that the applied volume is above the threshold value required for full wetting of all paper layers and the transport of target antibody and furimazine substrate to the LUMABS-modified detection areas.Nosignificant differences in colorimetric response were found when varying the volume of applied sample up to af actor of three (20 mL-60 mL). In as tudy on the storage stability of 3D-mPA Ds,fully assembled devices modified with anti-HIV-LUMABS were kept under inert gas (Ar) atmosphere at À20 8 8Cf or two months and the response to anti-HIV1 antibodies was tested sporadically.A st he data in Figure S6 reveals,n os ignificant deterioration was observed.
To evaluate the suitability of the 3D-mPA Ds for antibody detection in biological samples,w en ext performed experiments in antibody-spiked porcine serum. As observed previously,t he absolute bioluminescence emission intensities decreased when switching from aqueous solutions to the blood serum matrix, which has been attributed to al ower activity of the NanoLuc enzyme in that matrix.
[11a] Fort his reason, the amount of LUMABS deposited onto signal detection areas was increased to 500 fmol for all of the investigated sensor variants.F igure S7 shows the response curves obtained in the serum matrix. Linear regression fits were applied to the linear segments of the experimental data. Response curves expanded for the low antibody-concentration range were used to determine limits of detection using the 3s method, yielding LODs of 2.8 nm,7.1 nm, and 19.3 nm for anti-HIV1, anti-HA, and anti-DEN1, respectively (Figure S7 d-f) . Having established the performance in blood serum, we finally tested the 3D-mPA Ds using whole blood spiked with three different antibodies at variable concentrations.I nt his case,r ed and white blood cells,a sw ell as platelets,a re removed by the blood separation membrane integrated into the device.First, we established the minimally required volume of whole blood by applying different volumes of whole blood spiked with 50 nm of anti-HA ( Figure 4a ). Not surprisingly,c onsidering the solid constituents of whole blood (haematocrit value), the application of 20 mLofsample did not result in sufficient sample transport to the signal detection areas.R eliable assays required 30 mLo r higher volumes of whole blood as shown by the constant hue signal obtained with 30 mLt o6 0mLo fs ample.I na ddition, incubation times were increased from 15 min to 21 min to cope with the higher viscosity of whole blood compared to aqueous solutions or serum and the time required for blood separation within the device. Figure 4b shows that hue values increased during the first 18 min after whole blood application, while the response was nearly instantaneous in the case of aqueous antibody solutions. Figure 4c shows the results of quantitative recovery experiments in whole blood spiked with different concentrations of three different antibodies.Quantification was done using calibration data obtained with porcine serum samples ( Figure S7 a-c) , assuming that there are no significant differences in response behavior towards blood serum and blood plasma generated by the plasma separation membrane. Although the standard deviation is larger for whole blood, there is areasonable agreement between added (spiked) and actually measured mean antibody concentration values for both blood samples containing single target antibodies and mixtures of multiple antibodies (Figure 4c) .
To the best of our knowledge,t his is the first demonstration of afully integrated paper-based analytical system relying on ratiometric bioluminescence detection in as ingle drop of whole blood in ah ighly user-friendly "just add the sample" manner.Because the response of the system is independent of the applied sample volume over aw ide volume range,n o complex reagent handling and no quantitative sample metering are required. Although astandard digital camera was used in this study for signal acquisition, future applications of the 3D-mPA Ds may use as martphone camera, allowing integration of signal detection and application-based analysis without adedicated measurement instrument.
[11a] Theapplication of these 3D-mPA Ds is also not restricted to LUMABS-based detection of antibodies but may be combined with any BRETbased sensor,including recently developed sensors for smallmolecule drugs (LUCIDs) [12] and nucleic acids (BRETbeacons). [13] As such, this work represents an important advance in the field of POCT by enabling the transfer of paper-based analytical device technology from academic research laboratories to the market place. 
